GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1%
Wed, 28 Aug

GLENMARK PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

GLENMARK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m21,65625,63523,229-9.4%7.3%
Other incomeRs m1,38239117-95.7%-98.8%
TurnoverRs m23,03826,02523,245-10.7%0.9%
ExpensesRs m18,18721,99319,810-9.9%8.9%
Gross profitRs m3,4693,6413,419-6.1%-1.4%
DepreciationRs m79481090712.1%14.3%
InterestRs m79081993013.6%17.7%
Profit before taxRs m3,2672,4031,598-33.5%-51.1%
TaxRs m937786506-35.7%-46.1%
Profit after taxRs m2,3301,6171,093-32.4%-53.1%
Gross profit margin%16.014.214.7
Effective tax rate%28.732.731.6
Net profit margin%10.16.24.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 7.3% on a year-on-year (YoY) basis. The expenses were up by 8.9% YoY during the same period.
  • The company's operating profit declined by 1.4% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.7% in 1QFY20 as against 16.0% in 1QFY19.
  • Depreciation charges increased by 14.3% and finance costs increased by 17.7% YoY, respectively.
  • Other income declined by 98.8% YoY during the quarter.
  • Net profit for the quarter declined by 53.1% YoY. Net profit margins during the quarter declined from 10.1% in 1QFY19 to 4.7% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 9.4% on a quarter-on-quarter (QoQ) basis. The expenses were down by 9.9% QoQ during the same period.
  • The company's operating profit declined by 6.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 14.7% in 1QFY20 as against 14.2% in 4QFY19.
  • Net profit for the quarter declined by 32.4% QoQ, while net profit margins declined from 6.2% in 4QFY19 to 4.7% in 1QFY20.

To see how GLENMARK PHARMA has performed over the last eight quarters,please visit here.

GLENMARK PHARMA Share Price Performance

Over the last one year,GLENMARK PHARMA share price has moved down from Rs 643.4 to Rs 377.3, registering a Loss of Rs 266.2 or around 41.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,548.7 (down 0.1%). Over the last one year it has moved down from 15,533.1 to 12,548.7, a gain of 2,984 points (down 19.2%).

Overall, the S&P BSE SENSEX is down 3.2% over the year.

Current Valuations

At the current price of Rs 377.3, the price to earnings (P/E) ratio of GLENMARK PHARMA stands at 12.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.0 times.

Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1%". Click here!

  

Related Views on News

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 11.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, GLENMARK PHARMA has posted a net profit of Rs 1 bn (up 11.1% YoY). Sales on the other hand came in at Rs 26 bn (up 15.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Oct 24, 2019 09:31 AM

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - MYLAN COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS